We collected information about Agenebio Inc Hours for you. Follow the liks to find out everything about Agenebio Inc Hours.
AgeneBio's mission is to discover and develop innovative therapeutics for patients at risk for neurological and psychiatric conditions. Our lead late-stage clinical program is focused on prevention of Alzheimer’s dementia.
https://www.yellowpages.com/baltimore-md/mip/agenebio-inc-497716557
Get reviews, hours, directions, coupons and more for Agenebio Inc at 601 S Charles St, Baltimore, MD 21230. Search for other Pharmaceutical Products-Wholesale & Manufacturers in Baltimore on The Real Yellow Pages®.
https://agenebio.com/about-us/contact-us/
AgeneBio, Inc. 1340 Smith Avenue Suite 200 Baltimore, MD 21209 410.779.1260 ullscreen"> Investor Contact Michela Gallagher Founder and CEO [email protected] Media Contact Hilary Lefebvre [email protected] 212.300.4929 Contact Form
https://agenebio.com/about-us/
AgeneBio is dedicated to developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. Our mission is to discover and develop innovative therapeutics that preserve and restore brain function for patients at risk for neurodegeneration , to benefit the lives ...
https://agenebio.com/about-us/management/
She led the Phase 2 trial of AGB101 and initiation of AgeneBio’s drug discovery program to develop selective GABA alpha 5 positive allosteric modulators. Read More Michela Gallagher, PhD is the Krieger-Eisenhower Professor of Psychological and Brain Science, heads the Neurogenetics and Behavior Center at Johns Hopkins University and has ...
https://agenebio.com/about-us/recent-news/
Darryle Schoepp, Ph.D. joins the AgeneBio Board of Directors. December 8, 2019 AgeneBio, Inc. panel participation at American College of Neuropsychopharmacology meeting (ACNP) Bridging the Gap From Research Discovery to a Bonafide Neurotherapeutic: Sponsored by NIH Blueprint Neurotherapeutic Program
https://www.linkedin.com/company/agenebio-inc-
AgeneBio, Inc., is an emerging pharmaceutical company dedicated to developing innovative therapeutics that prevent neurodegeneration and preserve and restore cognitive function for …
https://www.crunchbase.com/organization/agenebio
Phone Number (410) 685-3000. AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company is headquartered in Indianapolis but conducts …
https://www.sec.gov/Archives/edgar/data/1467758/000146775814000002/xslFormDX01/primary_doc.xml
Name of Issuer; AgeneBio, Inc. Street Address 1 Street Address 2; 601 S. CHARLES STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer
https://www.sec.gov/Archives/edgar/data/1467758/000114036111058598/xslFormDX01/primary_doc.xml
Name of Issuer; AgeneBio, Inc. Street Address 1 Street Address 2; 11711 N. Meridian Street: Suite 520: City State/Province/Country ZIP/PostalCode Phone Number of Issuer
Searching for Agenebio Inc Hours?
You can just click the links above. The info is collected for you.
